CYC.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 02:10):

Stats
Today's Volume	12 000.00
Average Volume	21 893.00
Market Cap	167.66M
EPS	$0 ( 2024-02-27 )
Last Dividend	$0.00500 ( 2023-09-01 )
Next Dividend	$0 ( N/A )
P/E	-35.60
ATR14	$0 (0.00%)

Cyclopharm Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cyclopharm Ltd Financials

Annual	2023
Revenue:	$27.14M
Gross Profit:	$4.50M (16.57 %)
EPS:	$-0.0507

Q4	2023
Revenue:	$10.62M
Gross Profit:	$-930 707 (-8.77 %)
EPS:	$-0.0192

Q2	2023
Revenue:	$15.72M
Gross Profit:	$4.39M (27.89 %)
EPS:	$-0.0315

Q4	2022
Revenue:	$11.81M
Gross Profit:	$2.55M (21.60 %)
EPS:	$-0.0435

Financial Reports:

No articles found.

Cyclopharm Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.00500 (N/A)	$0 (N/A)	$0.00500 (N/A)	$0 (N/A)	$0.00500 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cyclopharm Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00496	2015-10-02
Last Dividend	$0.00500	2023-09-01
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	$0.0848	--
Avg. Dividend % Per Year	0.00%	--
Score	1.17	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-19)

$0.00509 Estimate 7.42 %

Dividend Stability

0.30 Very Poor

Dividend Score

1.17

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
WTC.AX	Ex Dividend Knight	2023-09-08	Semi-Annually	0.00%
FEX.AX	Ex Dividend Knight	2023-09-01	Annually	0.00%
PMC.AX	Ex Dividend Junior	2023-08-24	Semi-Annually	0.00%
ARB.AX	Ex Dividend Knight	2023-10-05	Semi-Annually	0.00%
IDX.AX	Ex Dividend Junior	2023-08-31	Semi-Annually	0.00%
SCG.AX	Ex Dividend Junior	2023-08-17	Annually	0.00%
CAR.AX	Ex Dividend Knight	2023-09-15	Semi-Annually	0.00%
MAD.AX	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
TER.AX	Ex Dividend Junior	2023-06-08	Annually	0.00%
CTE.AX	Ex Dividend Knight	2023-09-07	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.178	1.500	-3.57	-5.35	[0 - 0.5]
returnOnAssetsTTM	-0.102	1.200	-3.41	-4.10	[0 - 0.3]
returnOnEquityTTM	-0.140	1.500	-2.67	-4.00	[0.1 - 1]
payoutRatioTTM	-0.188	-1.000	-1.882	1.882	[0 - 1]
currentRatioTTM	3.48	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.26	0.800	1.391	1.113	[0.8 - 2.5]
cashRatioTTM	1.353	1.500	3.60	5.39	[0.2 - 2]
debtRatioTTM	0.0921	-1.500	8.47	-10.00	[0 - 0.6]
interestCoverageTTM	-44.83	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.0765	2.00	-0.0255	-0.0510	[0 - 30]
freeCashFlowPerShareTTM	-0.0822	2.00	-0.0411	-0.0822	[0 - 20]
debtEquityRatioTTM	0.131	-1.500	9.48	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.131	1.000	-1.147	-1.147	[0.2 - 0.8]
operatingProfitMarginTTM	-0.368	1.000	-9.35	-9.35	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.703	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.574	0.800	9.51	7.61	[0.5 - 2]
Total Score				-0.485

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-35.73	1.000	-3.71	0	[1 - 100]
returnOnEquityTTM	-0.140	2.50	-1.714	-4.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0822	2.00	-0.0274	-0.0822	[0 - 30]
dividendYielPercentageTTM	0.280	1.500	3.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0765	2.00	-0.0255	-0.0510	[0 - 30]
payoutRatioTTM	-0.188	1.500	-1.882	1.882	[0 - 1]
pegRatioTTM	0.145	1.500	-2.37	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.273	1.000	-9.33	0	[0.1 - 0.5]
Total Score				-1.931

Cyclopharm Ltd

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.